Surgery Partners sees 2026 revenue USD 3.08 billion-3.18 billion, adjusted EBITDA at least USD 489 million

Surgery Partners updated its 2026 outlook following the completed sale of its Idaho Falls facilities to Intermountain Health.

• Revenue forecast cut to $3.08 billion-$3.18 billion; adjusted EBITDA is expected to be at least $489 million, reflecting the remaining-year removal of Idaho Falls.
• Pro forma excluding Idaho Falls for the full year: revenue of $2.6 billion-$2.67 billion; adjusted EBITDA of at least $414 million.
• The deal delivered $797 million in gross proceeds and $587 million in net cash proceeds; proceeds are earmarked mainly for debt paydown.
• Leverage under the credit agreement is expected to improve 30 bps from 4.4x at the end of Q2 2026.